Search results for "Coronavirus"


 
Results 11 - 20 of about 166 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

New COVID-19 vaccines tested, authorization changes in progress for existing vaccines

The FDA further limited use of the Johnson & Johnson (Janssen) vaccine and scheduled advisory committee meetings on other vaccine questions. Two non-mRNA vaccines showed effectiveness, and other studies looked at antibody prevalence, home test accuracy, and long-term symptoms.
https://acpinternist.org/weekly/archives/2022/05/10/2.htm
10 May 2022

Register now for ACP and Annals of Internal Medicine's COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19

During the May 24 virtual live event, a panel of experts will discuss challenges related to the care of patients who have lasting symptoms following acute SARS-CoV-2 infection.
https://acpinternist.org/weekly/archives/2022/05/17/3.htm
17 May 2022

Higher risk for DVT, PE, bleeding seen after COVID-19; long-term risk for VTE recurrence may be low

A Swedish study found that patients who had COVID-19 were at higher risk for a first deep venous thrombosis (DVT) for up to three months, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while a single-center study from France found that risk for venous thromboembolism (VTE) recurrence up to a year after COVID-19 was low.
https://acpinternist.org/weekly/archives/2022/04/12/2.htm
12 Apr 2022

Frequency of COVID-19 rebound debated in research, ACP/Annals forum

Two letters reported on SARS-CoV-2 viral rebound among patients taking nirmatrelvir-ritonavir. The latest ACP and Annals of Internal Medicine forum brought experts together to discuss this and other clinical challenges in COVID-19 prevention and management on Wednesday, Sept. 7.
https://acpinternist.org/weekly/archives/2022/09/13/2.htm
13 Sep 2022

Register now for ACP and Annals of Internal Medicine's COVID-19 Forum X: Current Clinical Challenges in COVID-19 Prevention and Management

During the Sept. 7 virtual live event, a panel of experts will discuss current methods for preventing and managing SARS-CoV-2 infection.
https://acpinternist.org/weekly/archives/2022/08/30/4.htm
30 Aug 2022

Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine

Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://acpinternist.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022

New COVID-19 vaccine authorized; reviews analyze myocarditis, drug treatments

The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
https://acpinternist.org/weekly/archives/2022/07/19/4.htm
19 Jul 2022

Payment parity for phone calls, COVID-19 research on remdesivir, other drugs

COVID-19-related disparities were also in the news this week.
https://acpinternist.org/weekly/archives/2020/05/04/1.htm
4 May 2020

My ‘Zoom’ presidency

ACP's President reflects on how the pandemic has changed her ability to interact with members, patients, and even her own family.
https://acpinternist.org/archives/2020/09/my-zoom-presidency.htm
1 Sep 2020

Treating the lingering effects of COVID-19

An expert offered tips on helping patients who catch the novel coronavirus and then can't shake the symptoms.
https://acpinternist.org/archives/2021/01/treating-the-lingering-effects-of-covid-19.htm
1 Jan 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next